PerkinElmer (PKI) agrees to buy Caliper Life Sciences (CALP) for $10.50 a share, a 42% premium over yesterday's closing price. The $600M deal adds "innovative molecular imaging and detection technologies" to PerkinElmer's portfolio, according to its CEO. Shares of CALP +40% premarket.
PerkinElmer (PKI) agrees to buy Caliper Life Sciences (CALP) for $10.50 a share, a 42% premium...
From other sites
at CNBC.com (May 5, 2014)
at CNBC.com (Apr 23, 2014)
at CNBC.com (Jan 29, 2014)
at CNBC.com (Dec 17, 2013)
at CNBC.com (Sep 16, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs